CLINICAL TRIALS PROFILE FOR CARVEDILOL PHOSPHATE
✉ Email this page to a colleague
All Clinical Trials for Carvedilol Phosphate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00123903 ↗ | COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria | Terminated | GlaxoSmithKline | Phase 3 | 2005-07-01 | This study was designed to determine whether COREG MR is more effective than TOPROL-XL in reducing microalbuminuria in type 2 diabetic or non-diabetic patients with high blood pressure and microalbuminuria. |
| NCT00273052 ↗ | COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension | Completed | GlaxoSmithKline | Phase 3 | 2006-01-05 | This study was designed to determine whether treatment with COREG MR is more effective at maintaining a better lipid profile than treatment with TOPROL-XL for hypertension. |
| NCT00323037 ↗ | A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure | Completed | CTI Clinical Trial and Consulting Services | Phase 3 | 2006-03-01 | The purpose of this study is to determine if Coreg CR is as effective as Coreg IR in improving heart function in subjects with stable chronic heart failure. |
| NCT00323037 ↗ | A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure | Completed | GlaxoSmithKline | Phase 3 | 2006-03-01 | The purpose of this study is to determine if Coreg CR is as effective as Coreg IR in improving heart function in subjects with stable chronic heart failure. |
| NCT00323037 ↗ | A Study to Compare the Effects of Coreg CR and Coreg IR on Heart Function in Subjects With Stable Chronic Heart Failure | Completed | CTI-1, LLC | Phase 3 | 2006-03-01 | The purpose of this study is to determine if Coreg CR is as effective as Coreg IR in improving heart function in subjects with stable chronic heart failure. |
| NCT00553969 ↗ | Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease | Completed | GlaxoSmithKline | Phase 1/Phase 2 | 2007-11-01 | This study will examine the individual and combined effects of Coreg CR and lisinopril, on cardiovascular health as measured by Rasmussen Disease Score (RDS) in a blinded, placebo controlled comparison over a 9-month study period. Patients to be randomized will have pre-hypertensive blood pressures that do not require anti-hypertensive therapy and at least one additional cardiovascular risk factor. |
| NCT00553969 ↗ | Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease | Completed | University of Minnesota | Phase 1/Phase 2 | 2007-11-01 | This study will examine the individual and combined effects of Coreg CR and lisinopril, on cardiovascular health as measured by Rasmussen Disease Score (RDS) in a blinded, placebo controlled comparison over a 9-month study period. Patients to be randomized will have pre-hypertensive blood pressures that do not require anti-hypertensive therapy and at least one additional cardiovascular risk factor. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Carvedilol Phosphate
Condition Name
Clinical Trial Locations for Carvedilol Phosphate
Trials by Country
Clinical Trial Progress for Carvedilol Phosphate
Clinical Trial Phase
Clinical Trial Sponsors for Carvedilol Phosphate
Sponsor Name
